Function of NKG2D in natural killer cell-mediated rejection of mouse bone marrow grafts

Nature Immunology

Volumn 6, Issue 9, 2005, Pages 938-945

  Ogasawara, Kouetsu ^a,b   Benjamin, Jonathan ^a   Takaki, Rayna ^a,c   Phillips, Joseph H ^d   Lanier, Lewis L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIGAND; NATURAL KILLER CELL RECEPTOR NKG2D; NEUTRALIZING ANTIBODY; RETINOIC ACID EARLY INDUCIBLE 1 PROTEIN; UNCLASSIFIED DRUG; CARRIER PROTEIN; HLA ANTIGEN CLASS 1; IMMUNOGLOBULIN RECEPTOR; MEMBRANE PROTEIN; MINOR H ANTIGEN H60; MINOR HISTOCOMPATIBILITY ANTIGEN; MONOCLONAL ANTIBODY; NATURAL KILLER CELL ACTIVATING RECEPTORS; RAET1A PROTEIN, MOUSE; UL16 BINDING PROTEIN 1, MOUSE;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; GRAFT RECIPIENT; GRAFT REJECTION; IMMUNOCOMPETENCE; MOUSE; MOUSE STRAIN; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; RECEPTOR UPREGULATION; STEM CELL; TRANSGENIC MOUSE; ANIMAL; BONE MARROW TRANSPLANTATION; COMPARATIVE STUDY; IMMUNOLOGY; METABOLISM; MOUSE MUTANT;

ANIMALS; ANTIBODIES, MONOCLONAL; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CARRIER PROTEINS; GRAFT REJECTION; HISTOCOMPATIBILITY ANTIGENS CLASS I; KILLER CELLS, NATURAL; LIGANDS; MEMBRANE PROTEINS; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; MICE, TRANSGENIC; MINOR HISTOCOMPATIBILITY ANTIGENS; RECEPTORS, IMMUNOLOGIC;

EID: 24944455539     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni1236     Document Type: Article

References (40)

1. Lanier, L.L. NK cell recognition. Annu. Rev. Immunol. 23, 225-274 (2005).
2. Kiessling, R. et al. Evidence for a similar or common mechanism for natural killer cell activity and resistance to hemopoietic grafts. Eur. J. Immunol. 7, 655-663 (1977).
3. Lotzova, E., Savary, C.A. & Pollack, S.B. Prevention of rejection of allogeneic bone marrow transplants by NK 1.1 antiserum. Transplantation 35, 490-494 (1983).
4. Murphy, W.J., Kumar, V. & Bennett, M. Rejection of bone marrow allografts by mice with severe combined immune deficiency (scid). Evidence that natural killer cells can mediate the specificity of marrow graft rejection. J. Exp. Med. 165, 1212-1217 (1987).
5. Murphy, W.J., Kumar, V. & Bennett, M. Natural killer cells activated with interleukin 2 in vitro can be adoptively transferred and mediate hematopoietic histocompatibility-1 antigen-specific bone marrow rejection in vivo. Eur. J. Immunol. 20, 1729-1734 (1990).
6. Cudkowicz, G. & Stimpfling, J.H. Induction of immunity and of unresponsiveness to parental marrow grafts in adult F-1 hybrid mice. Nature 204, 450-453 (1964).
7. Cudkowicz, G. & Bennett, M. Peculiar immunobiology of bone marrow allografts. II. Rejection of parental grafts by resistant F 1 hybrid mice. J. Exp. Med. 134, 1513-1528 (1971).
8. Rembecki, R.M., Kumar, V., David, C.S. & Bennett, M. Bone marrow cell transplants involving intra-H-2 recombinant inbred mouse strains. Evidence that hemopoietic histocompatibility-1 (Hh-1) genes are distinct from. H-2D or H-2L. J. Immunol. 141, 2253-2260 (1988).
9. b bone marrow grafts. J. Exp. Med. 170, 191-202 (1989).
10. f. Eur. J. Immunol. 21, 2821-2828 (1991).
11. Yu, Y.Y.L. et al. The role of Ly49A and 5E6 (Ly49C) molecules in hybrid resistance mediated by murine natural killer cells against normal T cell blasts. Immunity 4, 67-76 (1996).
12. b bone marrow allografts in mice. Int. Immunol. 8, 1833-1839 (1996).
13. Raulet, D.H. Roles of the NKG2D immunoreceptor and its ligands. Nat. Rev. Immunol. 3, 781-790 (2003).
14. Diefenbach, A. et al. Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D. Nat. Immunol. 3, 1142-1149 (2002).
15. Radaev, S. & Sun, P.D. Structure and function of natural killer cell surface receptors. Annu. Rev. Biophys. Biomol. Struct. 32, 93-114 (2003).
16. Cerwenka, A. et al. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 12, 721-727 (2000).
17. Diefenbach, A., Jamieson, A.M., Liu, S.D., Shastri, N. & Raulet, D.H. Ligands for the murine NKG2D receptor: Expression by tumor cells and activation of NK cells and macrophages. Nat. Immunol. 1, 119-126 (2000).
18. Carayannopoulos, L.N., Naidenko, O.V., Fremont, D.H. & Yokoyama, W.M. Murine UL16-binding protein-like transcript 1: A newly described transcript encoding a high-affinity ligand for murine NKG2D. J. Immunol. 169, 4079-4083 (2002).
19. Nomura, M. et al. Genomic structures and characterization of Rae1 family members encoding GPI-anchored cell surface proteins and expressed predominantly in embryonic mouse brain. J. Biochem. 120, 987-995 (1996).
20. Zou, Z., Nomura, M., Takihara, Y., Yesunaga, T. & Shimada, K. Isolation and characterization of retinoic acid-inducible cDNA clones in F9 cells: a novel cDNA family encodes cell surface proteins sharing partial homology with MHC class I molecules. J. Biochem. 119, 319-328 (1996).
21. Cerwenka, A. & Lanier, L.L. NKG2D ligands: Unconventional MHC class I-like molecules exploited by viruses and cancer. Tissue Antigens 61, 335-343 (2003).
22. Malarkannan, S. et al. The molecular and functional characterization of a dominant minor H antigen, H60. J. Immunol. 161, 3501-3509 (1998).
23. Ogasawara, K. et al. NKG2D blockade prevents autoimmune diabetes in NOD mice. Immunity 20, 757-767 (2004).
24. Ogasawara, K. et al. Impairment of NK cell function by NKG2D modulation m NOD mice. Immunity 18, 41-51 (2003).
25. George, T.C., Ortaldo, J.R., Lemieux, S., Kumar, V. & Bennett, M. Tolerance and alloreactivity of the Ly49D subset of murine NK cells. J. Immunol. 163, 1859-1867 (1999).
26. b mouse bone marrow transplants. J. Immunol. 164, 1793-1799 (2000).
27. Raziuddin, A. et al. Differential effects of the rejection of bone marrow allografts by the depletion of activating versus inhibiting Ly-49 natural killer cell subsets. J. Immunol. 160, 87-94 (1998).
28. Bix, M. et al. Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice. Nature 349, 329-331 (1991).
29. Nakamura, M.C. et al. Mouse Ly-49D recognizes H-2Dd and activates natural killer cell cytotoxicity. J. Exp. Med. 189, 493-500 (1999).
30. George, T.C., Mason, L.H., Ortaldo, J.R., Kumar, V. & Bennett, M. Positive recognition of MHC class I molecules by the Ly49D receptor of murine NK cells. J. Immunol. 162, 2035-2043 (1999).
31. Drizlikh, G., Schmidt-Sole, J. & Yankelevich, B. Involvement of the K and I regions of the H-2 complex in resistance to hemopoietic allografts. J. Exp. Med. 159, 1070-1082 (1984).
32. Aguila, H.L. & Weissman, I.L. Hematopoietic stem cells are not direct cytotoxic targets of natural killer cells. Blood 87, 1225-1231 (1996).
33. Ehrlich, L.I.R. et al. Engagement of NKG2D by cognate ligand or antibody alone is insufficient to mediate costimulation of human and mouse CD8+ T cells. J. Immunol. 174, 1922-1931 (2005).
34. Bakker, A.B.H. et al. DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming. Immunity 13, 345-353 (2000).
35. Lodoen, M. et al. NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules. J. Exp. Med. 197, 1245-1253 (2003).
36. Lodoen, M. et al. The cytomegalovirus m155 gene product subverts NK cell antiviral protection by disruption of H60-NKG2D interactions. J. Exp. Med. 200, 1075-1081 (2004).
37. Murphy, W.J., Kumar, V. & Bennett, M. Acute rejection of murine bone marrow allografts by natural killer cells and T cells: Differences in kinetics and target antigens recognized. J. Exp. Med. 166, 1499-1509 (1987).
38. Ogasawara, K. et al. Requirement for IRF-1 in the microenvironment supporting development of natural killer cells. Nature 391, 700-703 (1998).
39. Ogasawara, K., Yoshinaga, S.K. & Lanier, L.L. Inducible costimulator costimulates cytotoxic activity and IFN-γ production in activated murine NK cells. J. Immunol. 169, 3676-3685 (2002).
40. Lanier, L.L., Ruitenberg, J.J. & Phillips, J.H. Functional and biochemical analysis of CD16 antigen on natural killer cells and granulocytes. J. Immunol. 141, 3478-3485 (1988).